Lucia Bio is a biotechnology company that focuses on developing Syk inhibitors that help in the treatment of immunological diseases.
Lucia Bio has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in August 2025.
Lucia Bio's investors include Uniseed, UniQuest Extension Fund.
Lucia Bio is headquartered in Camberwell, Australia.
Lucia Bio is a biotechnology company that focuses on developing Syk inhibitors that help in the treatment of immunological diseases.
Lucia Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lucia Bio — Funding & Investors." VCBacked, August 19, 2025, https://www.vcbacked.co/company/lucia-bio. Accessed August 13, 2026.
VCBacked. (2025). Lucia Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/lucia-bio
{{cite web |title=Lucia Bio — Funding & Investors |url=https://www.vcbacked.co/company/lucia-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated